Choose a language and wait for the translated text.
The new Isolator based fill and finish line has a total annual production capacity of 55 million units and equipped with three compounding suites with capacity for up to 2000 L bulks and disposable, single-use compounding and filling technologies.
Jubilant Pharmova’s US facility Line 3 gets FDA nod for commercial production | PharmaVoice
